Disclosed is a pharmaceutical tablet comprising 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'- hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) wherein the tablet is made using a diluent e.g. microcrystalline cellulose, powdered cellulose, pregelatinized starch, starch, lactitol, mannitol, sorbitol and maltodextrin for treating thrombocytopenia.